96906 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Alzheimer's disease; Amyloid plaque core protein
Nanoscale process to generate reagents selective for individual protein variants
#302Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
#303Methods and compositions for the generation and use of conformation-specific antibodies
#304STANDARD FOR QUANTIFYING PATHOGENIC AGGREGATES FROM PROTEINS PRODUCED NATURALLY IN THE BODY
#305Use of SAA1B/B homozygote in the prognosis and diagnosis of liver cirrhosis
#306Treatment of amyloidoses using myelin basic protein and fragments thereof
#307Modulation of activity of proneurotrophins
#308SAA domain-specific antibodies and peptide antagonists and use thereof to treat inflammatory diseases
#309Efficient production of peptides
#310ASSAY AND METHOD FOR IDENTIFYING COMPOUNDS THAT INHIBIT EXCITOTOXIC SIGNALS
#311Secreted proteins
#312Amyloid β-protein-specific production-inhibiting polypeptide
#313Method for producing synthetic amylospheroid
#314METHOD FOR ENHANCING IMMUNE RESPONSE WITH PEPTIDE
#315Prevention and Treatment of Amyloidogenic Disease
#316Cell growth-promoting peptide and use thereof
#317COMPOUND FOR TREATMENT OF ALZHEIMER'S DISEASE AND FAMILIAL DEMENTIA
#318Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type
#319Method for producing insoluble aggregate of neurodegenerative-disease-related protein
#320VACCINES FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE
#321IMMUNOLOGICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#322Treatment of myocardial injury with humanin analogs
#323Compositions and methods related to tauopathy
#324Polymutant tau protein variants and their use for recapitulating human tauopathies
#325Antibodies to phosphorylated tau aggregates
#326Biodegradable electroconducting nanowire, method of manufacture and uses thereof
#327Methods, compositions, and kits for detecting protein aggregates
#328Anti-Aβ globulomer 7C6 antibodies
#329TDP-43-storing cell model
#330Method of preparing antigen for acquiring anti-hydrophobic peptide antibody
#331Methods and compositions for monitoring phagocytic activity
#332Method for enhancing immune response with peptide
#333Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#334Fusion proteins and methods for treating HIV infection and AIDS related symptoms
#335Use of an anti-Tau pS422 antibody for the treatment of brain diseases
#336HUMAN ANTI-TAU ANTIBODIES
#337Biological complex specific for Alzheimer's disease detection in vitro and use thereof
#338Stabilized amyloid-beta oligomers and uses thereof
#339Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
#340Vaccine for treatment of tautopathy
#341Transgenic mouse model expressing amyloid β 4-42 peptide
#342Transgenic animal expressing Alzheimer's tau protein
#343Compound and method for treatment of alzheimer's disease and familial dementia
#344DNA vaccine for Alzheimer's disease
#345Methods for enhancing neprilysin activity and degrading amyloid-beta peptides and oligomers in a subject with Alzheimer's disease
#346Diagnosis of alzheimer's disease using Aβ22(pE)-42 peptide
#347Oligomer-specific amyloid beta epitope and antibodies
#348AMYLOID BETA PEPTIDES, ASSEMBLIES THEREOF, AND RELATED METHODS
#349SAP variants and their use
#350Prevention And Treatment Of Amyloidogenic Disease
#351Amyloid Precursor Protein E2 Domain and Uses Thereof
#352IN VIVO SCREENING MODELS FOR TREATMENT OF QC-RELATED DISORDERS
#353TREATMENT OF TYPE 2 DIABETES, METABOLIC SYNDROME, MYOCARDIAL INJURY AND NEURODEGENERATION WITH HUMANIN AND ANALOGS THEREOF
#354YEAST CELLS EXPRESSING AMYLOID BETA AND USES THEREFOR
#355Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
#356Methods and compositions for the generation and use of conformation-specific antibodies
#357Yeast cells expressing amyloid beta and uses therefor
#358Method for treating amyloid disease
#359ASSAYS AND METHODS PERTAINING TO PRE-AMYLOID INTERMEDIATES
#360Peptides that specifically target amyloid deposits
#361Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
#362PEPTIDE PROBE FOR RAPID AND SPECIFIC DETECTION OF AMYLOID AGGREGATION
#363IMMUNOLOGICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#364IMMUNOASSAY STANDARDS AND MEASUREMENT OF CLINICAL BIOMARKERS USING INTRA-ASSAY CALIBRATION STANDARDS
#365Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
#366LIPID COFACTORS FOR FACILITATING PROPOGATION OF PRPsc
#367BACTERIOPHAGES EXPRESSING AMYLOID PEPTIDES AND USES THEREOF
#368Prevention and Treatment of Amyloidogenic Disease
#369PREVENTION, TREATMENT AND DIAGNOSIS OF DISEASES ASSOCIATED WITH BETA-AMYLOID FORMATION AND/OR AGGREGATION
#370TREATMENT OF TAUOPATHIES
#371Treatment of tauopathies
#372DRUG SCREENING TARGET FOR ALZHEIMER'S DISEASE AND METHOD OF SCREENING POTENTIAL DRUGS
#373Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
#374Nucleic acid molecules encoding anti-amyloid beta antibodies
#375Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
#376Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory
#377MUTANT LOW-DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN WITH INCREASED BINDING TO ALZHEIMER AMYLOID-BETA PEPTIDE
#378Inhibitors of the nitration of amyloid β peptides and their uses in the diagnosis and treatment of Alzheimer's disease
#379Amyloid β fibrillogenesis-inhibiting peptide
#380METHOD OF TREATING NEURODEGENERATIVE DISEASE
#381Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell lines
#382PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
#383Composition and method for treating a tauopathy
#384Quantitative Aggregation Sensors
#385Screening for compounds that modulate GPR3-mediated beta-arrestin signaling and amyloid beta peptide generation
#386Method Of Screening Drugs For Reversal Of Amyloid Beta Neurotoxicity
#387Signature Of Secreted Protein Isoforms Specific To Ovarian Cancer
#388Method for enhancing immune response with peptide
#389N-Terminal Truncated Protofibrils/Oligomers for Use in Therapeutic and Diagnostic Methods for Alzheimer's Disease and Related Disorders
#390VECTOR FOR TREATING ALZHEIMER'S DISEASE
#391Human anti-tau antibodies
#392APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCER
#393Methods for identifying safe and functional humanized antibodies
#394METHODS RELATING TO PERIPHERAL ADMINISTRATION OF NOGO RECEPTOR POLYPEPTIDES
#395Vaccine composition for prophylaxis and/or therapy of Alzheimer's disease
#396Methods and compositions comprising supramolecular constructs
#397Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
#398Antibodies specific for amyloid beta protofibril
#399DNA VACCINE FOR ALZHEIMER'S DISEASE
#400Peptide probe for rapid and specific detection of β-amyloid aggregation
#401Immunotherapy for clearing pathological tau conformers
#402Prevention and Treatment of Amyloidogenic Disease
#403Aβ-binding protein and its peptide derivatives and uses thereof
#404Treatment of amyloidoses using myelin basic protein and fragments thereof
#405Alzheimer's Disease Secretase, APP Substrates Therefor, and Uses Therefor
#406CHIMERIC PEPTIDES AS IMMUNOGENS, ANTIBODIES THERETO, AND METHODS FOR IMMUNIZATION USING CHIMERIC PEPTIDES OR ANTIBODIES
#407Amyloid-beta peptide crystal structure
#408INHIBITORS OF AMYLOID FIBRIL FORMATION AND USES THEREOF
#409Modified amyloid β peptide
#410GAMMA-SECRETASE SUBSTRATE AND METHODS OF USE
#411Complex of a chaperone with β-amyloid and methods employing this complex
#412Amyloid-beta binding proteins
#413METHOD OF DIAGNOSING ALZHEIMER'S DISEASE USING GIANT MAGNETORESISTANCE SENSOR AND MAGNETIC BEAD-POLYPROTEIN COMPLEX FOR DIAGNOSING ALZHEIMER'S DISEASE
#414Composition for producing anti-amyloid beta peptide antibodies with D-peptides
#415Nucleobindin I variant protein compositions and methods of use
#416Compounds for reversing and inhibiting protein aggregation, and methods for making and using them
#417Immunotherapeutic compositions for the treatment of alzheimer'S disease
#418Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-B precursor protein and tissue inhibitor of metalloproteinase-2
#419Protein Aggregation Domains and Methods of Use Thereof
#420Vaccine against amyloid folding intermediate
#421Class of therapeutic protein based molecules
#422ANTIGENIC TAU PEPTIDES AND USES THEREOF
#423Compositions for inhibiting ABAD/ABeta protein interaction
#424Antisense Modulation Of Amyloid Beta Protein Expression
#425NOVEL DIAGNOSTIC METHOD
#426GAMMA-SECRETASE SUBSTRATE AND METHODS OF USE
#427Isolsted Monoclonal - Associated Protein Tau and Kit
#428Collagen-like protein CLAC, a precursor thereof, and genes encoding the same
#429Targeting TGF-β as a therapy for Alzheimer's disease
#430Crystal form of the amyloid precursor protein intracellular domain (AICD) in complex with human FE65-PTB2
#431SCREENING METHOD FOR AGENTS SUITABLE FOR PROPHYLAXIS AND THERAPY OF ALZHEIMER'S DISEASE (AD)
#432Efficient production of peptides
#433Beta sheet inhibiting peptides for preventing and/or treating Alzheimer's Disease
#434ABeta-OLIGOMER MEASUREMENT METHOD
#435CYTOTOXIC PEPTIDES AND PEPTIDOMIMETICS BASED THEREON, AND METHODS FOR USE THEREOF
#436Methods and system for the identification and characterization of peptides and their functional relationships by use of measures of correlation
#437Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses
#438Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
#439Stable amyloid beta monomers and oligomers
#440Use of an anti-Tau pS422 antibody for the treatment of brain diseases
#441Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs
#442TRANSGENIC MAMALS MODIFIELD IN BRI PROTEIN EXPRESSION
#443HEAT SHOCK PROTEIN DEFICIENCIES AS MODEL SYSTEMS FOR BRAIN PATHOLOGY AND CANCER
#444Small humanin-like peptides
#445TDP-43-storing cell model
#446Cellular model of tauopathies for lead identification and drug discovery
#447Histidine related compounds for identifying and blocking amyloid beta ion channels
#448METHODS FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE (AD)
#449MARKER PEPTIDE FOR ALZHEIMER'S DISEASE
#450MULTIMERIC PROTEINS ABLE TO INDUCE AN ANTIBODY RESPONSE AGAINST THE BETA-AMYLOID AND USE THEREOF
#451PRODUCTS AND THEIR USE FOR THE DIAGNOSIS, PREVENTION AND/OR CARE OF HUMAN AND/OR ANIMAL PATHOLOGIES CHARACTERISED BY THE ANOMALOUS DEPOSITION OF B-AMYLOID AND/OR AMYLOID-LIKE SUBSTANCE IN HUMAN AND/OR ANIMAL ORGANS AND TISSUES, AND SCREENING METHOD FOR DETERMINING THE RISK OF SUCH PATHOLOGIES
#452MODULATORS OF AMYLOID AGGREGATION
#453SAP variants and their use
#454METHODS AND SUBSTANCES FOR THE TREATMENT OF ALZHEIMER'S
#455QUADRUPLE TRANSGENIC NON-HUMAN ANIMAL
#456SIGNALING INTERMEDIATES IN AN IN VITRO MODEL OF ALZHEIMER'S DISEASE
#457BRI POLYPEPTIDES AND REDUCING AB AGGREGATION
#458Method for enhancing immune response with peptide
#459HUMAN FG01 GENE AND ITS APPLICATIONS
#460γ-Secretase substrates and methods of use
#461Method for therapeutic use
#462Compositions and methods for treating atherosclerosis
#463Antibodies for amyloid specific peptides
#464Compositions and Methods for Treating Atherosclerosis
#465USE OF A CAMELID SINGLE-DOMAIN ANTIBODY FOR DETECTING AN OLIGOMERIC FORM OF AN AMYLOID BETA PEPTIDE AND ITS APPLICATIONS
#466Composition and Method for a Producing Stable Amyloid Beta Oligomers of High Molecular Weight
#467Preparation of low bleeding anticoagulant fusion protein and its use
#468CONFORMATIONALLY DYNAMIC PEPTIDES
#469METHODS FOR THE PREPARATION OF FUNCTIONALIZED PEPTIDES, PROTEINS AND CARBOHYDRATES AND THEIR CONJUGATES
#470Chemically Modified Peptide Analogs
#471Modulation of activity of proneurotrophins
#472AMYLOID BETA(1-42) OLIGOMERS, DERIVATIVES THEREOF AND ANTIBODIES THERETO, METHODS OF PREPARATION THEREOF AND USE THEREOF
#473THE USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES
#474Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
#475Method of Screening Compounds Having Anti-Amyloid Properties
#476Aß(X - 38 .. 43) oligomers, and processes, compositions, and uses thereof
#477Anti-Aβ antibodies and their use
#478Amyloid beta peptides and methods of use
#479MEANS AND METHODS FOR ISOLATING AND DETERMINING NOVEL TARGETS FOR THE TREATMENT OF NEURODEGENERATIVE, NEUROLOGICAL OR NEUROPSYCHIATRIC DISORDERS AND COMPOSITIONS COMPRISING THE SAME
#480Switch-Peptides as Tool for the Study of Fibrillogenesis
#481DIAGNOSING NEURODEGENERATIVE DISEASES
#482MODULATION OF ANGIOGENESIS BY A-BETA PEPTIDE FRAGMENTS
#483SOLUBLE LOW-DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN BINDS DIRECTLY TO ALZHEIMER'S AMYLOID-BETA PEPTIDE
#484Preparation of low bleeding anticoagulant fusion protein and its use
#485Crystallization and Structure Determination of Glycosylated Human Beta Secretase, an Enzyme Implicated in Alzheimer's Disease
#486Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#487Secreted proteins
#488Means and methods for the production of amyloid oligomers
#489Truncated tau proteins
#490Peptide vaccine for inducing the production of anti-amyloid β-peptide antibody
#491Light emitting devices made by bio-fabrication
#492Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate
#493Amyloid-beta polypeptide vaccine
#494ANTI-AMYLOID IMMUNOGENIC COMPOSITIONS, METHODS AND USES
#495Peptides directed for diagnosis and treatment of amyloid-associated diseases
#496Human brain carboxypeptidase B
#497Molecular probe for sphingolipids
#498Mutants of Human App and Their Use for the Production of Transgenice Animals
#499NOVEL COLLAGEN-LIKE PROTEIN CLAC, PRECURSOR THEREOF AND GENES ENCODING THE SAME
#500NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#501Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
#502Transgenic pig model for a hereditary neurodegenerative autosomal dominant disease
#503PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#504Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
#505Anti-ADDLs antibodies and uses thereof
#506Collagen-like protein CLAC, precursor thereof and genes encoding the same
#507Devices from Prion-Like Proteins
#508Preferred segments of neural thread protein and method of using the same
#509Preparation of Purified Covalently Cross-linked Abeta Oligomers and Uses Thereof
#510Methods of Dissolving Beta-Sheet Proteins and Uses Thereof
#511Treatment methods using peptides related to amyloid precursor protein
#512ALZHEIMER'S DISEASE ANIMAL MODEL, METHOD FOR OBTAINING SAME AND USES THEREOF
#513Promoter mutations that increase amyloid precursor protein expression
#514Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
#515Method of screening for compounds that disaggregate amyloid aggregates
#516TEST AND MODEL FOR ALZHEIMER'S DISEASE
#517METHODS AND COMPOSITIONS FOR DISEASES ASSOCIATED WITH AMYLOIDOSIS
#518AGENTS FOR PRE-SYMPTOMATIC DETECTION AND THERAPEUTIC TARGETING OF ALZHEIMER'S DISEASE AND DOWN SYNDROME IN HUMANS
#519Methods for detecting the presence of mutant mammalian presenilin protein
#520Prevention and treatment of amyloidogenic disease
#521Anti-Aβ globulomer 5F7 antibodies
#522METHOD OF REDUCING THE EFFECTS OF ABeta AND COMPOSITIONS THEREFORE
#523Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
#524Alzheimer's Disease Secretase, APP Substrates Thereof, and Uses Thereof
#525Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease
#526Low-Density Lipoprotein Receptor-Related Protein 2 Clears Amyloid-Beta Peptide A cross the Blood-Brain Barrier via Apolipoprotein J
#527Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof
#528Isolated microtubule-associated protein tau peptides and kit
#529CONFORMATIONALLY ABNORMAL FORMS OF TAU PROTEINS AND SPECIFIC ANTIBODIES THERETO
#530Transgenic animal model for alzheimer's disease
#531Transgenic mouse models of Aβ overexpression
#532NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#533Amyloid [β] Beta fibrillogenesis-inhibiting peptide
#534Alzheimer's related proteins and methods of use
#535Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits
#536Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
#537Humanized antibodies that recognize beta amyloid peptide
#538Immunological methods and compositions for the treatment of Alzheimer's disease
#539Screening Method, Process for Purifying of Non-Diffusible A-Beta Oligomers, Selective Antibodies Against Said Non-Diffusible a-Beta Oligomers and a Process for Manufacturing of Said Antibodies
#540Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody
#541Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
#542Monoclonal antibody
#543Method of Treating Cognitive Decline and Synaptic Loss Related to Alzheimer's Disease
#544Recombinant adeno-associated virus vector for treatment of Alzheimer disease
#545Method for Diagnosing Neuro-Degenerative Disease
#546Compositions Comprising Addl Receptors, Related Compositions, and Related Methods
#547Substrates and assays for beta-secretase activity
#548Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
#549Novel BACE proteins, nucleic acid molecules therefor, novel crystal structure of novel BACE proteins, and methods for making and using
#550Antibody specific for mutant presenilin 2 and method of use thereof
#551HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE
#552COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER OR NEURODEGENERATIVE DISEASE WITH PEPTIDE BASED MICROTUBULE STABILIZERS OR INHIBITORS
#553Cog47 Protein and S100beta Gene Polymorphism
#554Methods and Compositions for Inhibiting Abad/Abeta Protein Interaction
#555Inducing neurofibrillary tangles in transgenic mice expressing a mutant tau protein
#556Methods of diagnosing or treating neurological diseases and cell degeneration
#557Peptides facilitating or inhibiting a nterograde transport
#558New Method 706
#559IMMUNIZATION AGAINST AMYLOID PLAQUES USING DISPLAY TECHNOLOGY
#560Cell Penetrating Peptides
#561PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#562Prevention and treatment of amyloidogenic disease
#563Humanized antibodies that recognize beta amyloid peptide
#564Digital alloys and methods for forming the same
#565Transformed plant cell expressing tandem repeats of beta-amyloid gene and plant produced by the same
#566Inhibition of tau-tau association
#567Method for the Diagnosis of Alzeimer's Disease
#568Drosophila Models For Diseases Affecting Learning and Memory
#569PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE
#570Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same
#571Saitohin gene and uses of same
#572COMPONENTS OF THE PRESENILIN-COMPLEX
#573Alzheimer's Disease Secretase, APP Substrates Therefor and Uses Therefor
#574Detection of conformationally altered proteins and prions
#575Screening method for an agent for treatment of neurodegenerative disease
#576Treatment methods using polypeptides related to amyloid precursor protein
#577Antigens targeted by prevalent pathogennic T cells in type 1 diabetes and uses thereof
#578SOLUBLE CYCLIC ANALOGUES OF BETA AMYLOID PEPTIDE
#579Tissue-Based Assay System for Alzheimer-Specific Degeneration and Pathology
#580Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide
#581PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#582Substrates and Assays for Beta Secretase Activity
#583Transgenic flies expressing tau and amyloid precursor fragment
#584Variant Amyloid Protein
#585Transgenic mice for screening for inhibitors of protein aggregation and methods for making and using them
#586Diagnostic and Therapeutic Use of Kcnc1 for Neurodegenerative Diseases
#587Tau fragments for immunotherapy
#588Humanized antibodies that recognize beta amyloid peptide
#589Preferential Inhibition of Presenilin-1
#590Neuroactive fragments of APP
#591Assemblies of Oligomeric Amyloid Beta Protein and Uses Thereof
#592Antiangiogenic peptides
#593Modulation of angiogenesis by A-beta peptide fragments
#594Inhibitors of Amyloid Fibril Formation and Uses Thereof
#595Methods, compositions, and kits for detecting protein aggregates
#596APPOPTOSIN AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASE AND CANCER
#597Beta-Amyloid Inhibitors and Use Thereof
#598HUMAN CDNAS AND PROTEINS AND USES THEREOF
#599Methods, Compositions, and Kits for Quantitating Antibodies
#600Method for improving memory in AD patients